SEC Form 4 · accession 0001209191-15-026987
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Evan/ Fa Jones
Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 17, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2015 | M | 6,248 | $4.16 | A | 6,248 | D | |
| Common Stock | Mar 16, 2015 | M | 3,828 | $7.12 | A | 10,076 | D | |
| Common StockF1 | holding | — | — | — | 55,309 | I | by jVen Capital, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.16 | Mar 16, 2015 | M | 6,248 | D | — | Mar 7, 2023 | Common Stock | 6,248 | 6,252 | D |
| Stock Opiton (right to buy)F3 | $7.12 | Mar 16, 2015 | M | 3,828 | D | — | May 22, 2023 | Common Stock | 3,828 | 4,922 | D |
Explanation of responses
- F1Shares held by jVen Capital, LLC, of which the reporting person is the managing member.
- F2This option was granted on March 7, 2013 and vests in equal quarterly installments beginning on April 10, 2013 until fully vested on January 10, 2017.
- F3This option was granted on May 22, 2013 and vests in equal quarterly installments beginning on May 22, 2013 until fully vested on May 22, 2017.